Asset-light operations
fully control the high-profit links of the industry chain



Ziteng Pharmaceutical Group is mainly engaged in the research and development, industrialization and sales of chemical generic drugs. It has the industry's first-class chemical drug generics technical team and a professional drug sales company with GSP qualification. It adopts a unique "self-operated R&D, sales + outsourced production" Model ("Hisco Model"), asset-light operation, full control of the high-profit links of the industry chain and continuous listing of new products, enabling the company to gain continuous and rapid growth momentum.

In recent years, the team has developed and stocked a number of products, forming a complete R&D pipeline, covering cardiovascular diseases, gynecology, tumors, analgesia, gastrointestinal tract, degenerative diseases and other fields.